SEC Form 4 · accession 0000899243-17-017199
ORAGENICS INC · OGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles L Pope
Director
Period of report
Jun 22, 2017
Accepted (ET)
Jun 26, 2017 · 3:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001174940
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Employee Director Option (Right to Buy)F1 | $0.37 | Jun 22, 2017 | A | 140,000 | A | Jun 22, 2017 | Jun 22, 2027 | Common Stock | 140,000 | 140,000 | D |
Explanation of responses
- F1Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a director. The options vest on the first anniversary of the grant date. The option exercise price is the closing price on the date of the grant, June 22, 2017